Cancer diagnostics.

Easy, accurate, now!

Our vision is a world where every cancer patient receives the right therapy.

Our mission is to supply the healthcare systems with the necessary solutions to assure the best possible use of the advanced cancer drugs.

What we offer

We  empower healthcare providers with CE/IVD-certified solutions from the tissue handling to the data analysis step of the diagnostic process

Approved software for analyses of tumors to guide the use of targeted therapies and checkpoint inhibitor

Fully automated extraction solution without manual reagent handling

Providing healthcare systems with solutions for highly accurate mutation detection

0
July

Oncodia was awarded Eurostars grand named "3D SELECT"

  • Uppsala Univesity, Sweden

The consortium of VitroScan, Anapath, FHNW, Robovision, Uppsala University  and Oncodia was awarded Eurostars grant for personalized ovarian cancer therapy selection in a multidisciplinary project, named “3D SELECT”

11 July 2019

Oncodia was awarded an EIT Health Head-Start grant

10 December 2018

In a ceremony at Uppsala University Innovation, Oncodia received the "Attractive Innovation Project Award"

4-5 December 2018

Oncodia attended BioFit2018, Lille, France

What our clients say

I’m a paragraph. Click here to add your own text and edit me. It’s easy. I’m a great place for you to tell a story.
5/5
Amazing customer experience all the way through! I've had some bad experiences in the past but this was just great!
Johan Andersson
Designer
5/5
Great service! I was treated in a serious and professional way despite asking a thousand questions. Superb!
Hannah Andersson
Manager
5/5
High quality and friendly encountaring from start to finish. Recommended to everyone who values real quality!
Fredrik Oliver
Support

Give us a Call 1-888-499-9240 and we can set you up, or read more about our services here

ABOUT US

Precision medicine delivered and right therapy

Our mission is to improve the use of advanced cancer drugs by providing healthcare systems with solutions for highly accurate mutation detection.

This project has received funding from the European Union’s Horizon 2020  research and innovation programme under grant agreement No 876876

News

woman-in-black-long-sleeved-top-1181317

Oncodia wins EuroStars grant

A multidisciplinary project for personalized ovarian cancer therapy selection, termed 3D-SELECT, was granted EUR €3.47 million, of which total subsidy ~ €1.82 million, on June

Read More »

Get in touch

About

Improving the use of advanced cancer drugs by providing healthcare systems with solutions for highly accurate mutation detection.